Common Stock, Shares Authorized of Contineum Therapeutics, Inc. from 10 Apr 2023 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Contineum Therapeutics, Inc. quarterly Common Stock, Shares Authorized in shares history and change rate from 10 Apr 2023 to 31 Mar 2024.
  • Contineum Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending 31 Mar 2024 was 39,630,511, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Contineum Therapeutics, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 39,630,511 0 0% 31 Mar 2024 10-Q 16 May 2024 2024 Q1
Q4 2023 39,630,511 31 Dec 2023 10-Q 16 May 2024 2024 Q1
Q1 2023 39,630,511 10 Apr 2023 10-Q 16 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.